Effect of low-, moderate-, and high-fat meals on raltegravir pharmacokinetics

J Clin Pharmacol. 2011 Mar;51(3):422-7. doi: 10.1177/0091270010367652. Epub 2010 May 10.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cross-Over Studies
  • Dietary Fats / administration & dosage*
  • Female
  • Food-Drug Interactions*
  • HIV Infections / drug therapy
  • HIV Integrase Inhibitors / adverse effects
  • HIV Integrase Inhibitors / blood
  • HIV Integrase Inhibitors / pharmacokinetics*
  • Humans
  • Male
  • Middle Aged
  • Pyrrolidinones / adverse effects
  • Pyrrolidinones / blood
  • Pyrrolidinones / pharmacokinetics*
  • Raltegravir Potassium
  • Young Adult

Substances

  • Dietary Fats
  • HIV Integrase Inhibitors
  • Pyrrolidinones
  • Raltegravir Potassium